| Followers | 2428 |
| Posts | 90875 |
| Boards Moderated | 7 |
| Alias Born | 09/12/2003 |
Monday, May 10, 2021 11:55:50 AM
$QNTA PENDING Escozine FDA IND APPROVAL in 3 days.
QNTA Tiny SS, O/S reducing. Quanta owned multi patents. Its rare to see a biotech company on Pinkyland actual reporting earnings millions of dollars. Quanta is still under radar, might becoming a runner like VXRT, OCGN or GNUS from penny to dollars. Imho:))
This is the moment we've been waiting for IND FDA approval.
[/quote]announced today that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic. Along with the submission of a batch of Escozine® previously announced specifically produced for the FDA, the Company believes that this will be the last submission necessary in order to receive IND designation from the regulatory body in the United States. [/quote]
https://www.globenewswire.com/news-release/2021/04/13/2209126/0/en/Medolife-Rx-Submits-Final-Data-Set-to-FDA-for-IND-Filing-on-Lead-Drug-Candidate.html
Escozine-HP™ Pretty Pricey and it's Truly a Cancer Cure...
https://escozine.net/
https://medolife.com/escozine-hp/
Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 06, 2021 08:00 ET | Source: Quanta, Inc.
https://www.globenewswire.com/news-release/2021/05/06/2224499/0/en/Medolife-Rx-Implements-Proprietary-Electro-Solution-Further-Increasing-Efficacy-of-Polarization-Technology.html
$QNTA All News
https://www.globenewswire.com/en/search/organization/Quanta%CE%B4%2520Inc%C2%A7
Chart looks poised for reversals
QNTA Tiny SS, O/S reducing. Quanta owned multi patents. Its rare to see a biotech company on Pinkyland actual reporting earnings millions of dollars. Quanta is still under radar, might becoming a runner like VXRT, OCGN or GNUS from penny to dollars. Imho:))
This is the moment we've been waiting for IND FDA approval.
[/quote]announced today that it has filed its final set of data requested by the US Food and Drug Administration (FDA) for its Pre-Investigational New Drug (PIND #150335) filing on its lead drug candidate Escozine® as a COVID-19 therapeutic. Along with the submission of a batch of Escozine® previously announced specifically produced for the FDA, the Company believes that this will be the last submission necessary in order to receive IND designation from the regulatory body in the United States. [/quote]
https://www.globenewswire.com/news-release/2021/04/13/2209126/0/en/Medolife-Rx-Submits-Final-Data-Set-to-FDA-for-IND-Filing-on-Lead-Drug-Candidate.html
Escozine-HP™ Pretty Pricey and it's Truly a Cancer Cure...
https://escozine.net/
https://medolife.com/escozine-hp/
Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 06, 2021 08:00 ET | Source: Quanta, Inc.
https://www.globenewswire.com/news-release/2021/05/06/2224499/0/en/Medolife-Rx-Implements-Proprietary-Electro-Solution-Further-Increasing-Efficacy-of-Polarization-Technology.html
$QNTA All News
https://www.globenewswire.com/en/search/organization/Quanta%CE%B4%2520Inc%C2%A7
Chart looks poised for reversals
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
